Aclaris Therapeutics, Inc.

ACRS ·Healthcare, Drug Manufacturers - General, United States
Balance Sheet Asset & Liabilities Breakdown

Asset & Liabilities Breakdown

Asset Breakdown FY2017

Total Assets: $243.5M

Liabilities Breakdown FY2017

Total Liabilities: $18.2M